Cargando…

Inhibition of complement activation: a novel mechanism for the protective effects of heparin in antiphospholipid antibody-induced pregnancy loss

Detalles Bibliográficos
Autores principales:	Girardi, G, Redecha, P, Salmon, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833543/ http://dx.doi.org/10.1186/ar1413

Ejemplares similares

Antiphospholipid antibodies harness innate effectors, neutrophils and an alternative pathway of complement, to induce fetal damage
por: Salmon, J, et al.
Publicado: (2003)

Natural antibodies and antiphospholipid antibodies bind to injured tissues, activate complement and cause tissue damage
por: Tsokos, G, et al.
Publicado: (2003)

Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
por: Holers, V. Michael, et al.
Publicado: (2002)

Atypical hemolytic-uremic syndrome associated with antiphospholipid antibodies and antiphospholipid syndrome; a novel presentation
por: Shiari, Reza, et al.
Publicado: (2014)

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016)

Avascular osteonecrosis mechanism – between osteoporosis and antiphospholipid syndrome
por: Negru, Anca Ruxandra, et al.
Publicado: (2014)

Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003)

Bouquet variety of antiphospholipid antibodies in recurrent pregnancy loss
por: Baleva, Marta P., et al.
Publicado: (2014)

Incidence and clinical relevance of heparin-induced antibodies in critically ill patients
por: Grigoriou, P, et al.
Publicado: (2004)

Artherial thrombosis with antiphospholipid syndrome in 17 year old female patient: case of familial antiphospholipid syndrome
por: Vidović, M, et al.
Publicado: (2011)

PReS-FINAL-2349: Spectrum of thrombotic and non-thrombotic manifestations in 159 children with positive antiphospholipid antibodies
por: Rozic, M, et al.
Publicado: (2013)

The urgent need for a multi-disciplinary core outcome set for the reporting of obstetric antiphospholipid antibody syndrome
por: Sankaran, Srividhya, et al.
Publicado: (2015)

High incidence of positive heparin antibodies in a multidisciplinary intensive care unit
por: Renieris, P, et al.
Publicado: (2007)

Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
por: Nalli, Cecilia, et al.
Publicado: (2021)

Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants
por: Skarzynski, Martin, et al.
Publicado: (2015)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
por: Lee, Eunyoung Emily, et al.
Publicado: (2021)

PReS-FINAL-2269: Incidence of antiphospholipid antibody syndrome in a cohort of children suffering from either arterial or venous thrombosis
por: Cancarini, P, et al.
Publicado: (2013)

Neutralization and enhancement of trans infection by erythrocyte-bound HIV with antibodies and complement
por: Beck, Z, et al.
Publicado: (2012)

Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome
por: Baiazid, Latifa, et al.
Publicado: (2022)

Nebulized heparin for patients under mechanical ventilation: a conventional data meta-analysis
por: Glas, GJ, et al.
Publicado: (2015)

Cell Damage at the Origin of Antiphospholipid Antibodies and Their Pathogenic Potential in Recurrent Pregnancy Loss
por: Piroux, Véronique, et al.
Publicado: (1997)

Infantile de novo primary antiphospholipid syndrome revealed by neonatal stroke
por: Merlin, E, et al.
Publicado: (2011)

Complement in the Pathophysiology of the Antiphospholipid Syndrome
por: Chaturvedi, Shruti, et al.
Publicado: (2019)

Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL) – Mediated Inhibition of Endometrial Angiogenesis
por: D'Ippolito, Silvia, et al.
Publicado: (2012)

Acute adrenal failure (AAF) as the presenting symptom of primary antiphospholipid syndrome (APS)
por: Russo, G, et al.
Publicado: (2011)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of the antiphospholipid syndrome
por: Groot, Noortje, et al.
Publicado: (2014)

25. Use of rituximab in refractory primary antiphospholipid syndrome with pulmonary and cerebral manifestations
por: Khan, Asim, et al.
Publicado: (2019)

Consequences of suspected heparin-induced thrombocytopenia in the ICU
por: Ostermann, M, et al.
Publicado: (2012)

PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012
por: Gazda, A, et al.
Publicado: (2013)

Heparin-induced thrombocytopenia incidence in the ICU: preliminary results
por: Barbani, F, et al.
Publicado: (2010)

Maintenance of arterial catheters with heparin: should we continue?
por: Catorze, N, et al.
Publicado: (2011)

Safety of heparin prophylaxis for venous thromboembolism in patients with neurotrauma
por: Puri, G, et al.
Publicado: (2010)

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Close association between valvular heart disease and central nervous system manifestations in antiphospholipid syndrome
por: Krause, I, et al.
Publicado: (2005)

Does protamine infusion reduce postoperative blood loss and heparin rebound in cardiac surgery patients? A retrospective analysis of 240 patients on the cardiac ICU
por: Helme, E, et al.
Publicado: (2013)

The beneficial effects of the combined methods in investigating heparin-induced thrombocytopenia
por: Kounavi, M, et al.
Publicado: (2007)

Extracorporeal renal replacement therapy in patients with heparin-induced thrombocytopenia
por: Bekers-Anchipolovskis, M, et al.
Publicado: (2009)

Lack of adalimumab's complement dependent cytotoxicity on human cells expressing complement regulatory proteins
por: Grebe, K M, et al.
Publicado: (2010)

P1637: PROTEOMIC PROFILING OF DIFFERENT ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PHENOTYPES: RESULTS FROM ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) REGISTRY
por: Butt, Ayesha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s72o4ltutb7bchdc14julp3u1f